Division of Baxano Surgical Inc.
Latest From TranS1 Inc.
The minimally invasive spine surgery device firm owes at least $7.6 million to its lender and is looking for bankruptcy protection as it plans to sell off its assets.
Device companies finished 2013 strong, raising $1.2 billion in Q4, the highest quarter total of the year. CVS Caremark’s $2.1 billion buy of Apria’s infusion therapy business was the largest M&A of the year, and late-stage venture rounds dominated the $423 million total in diagnostics funding.
Sales of Medtronic’s CoreValve blocked in Germany. Myriad Genetics sues BRCA test competitors. More news.
Device companies kicked off 2013 by raising $1.1 billion via 45 transactions; the only device M&A transaction in Q1 to exceed the billion-dollar mark was Cardinal Health Inc.’s $2.07 billion acquisition of AssuraMed. Diagnostics firms began 2013 by raising a total of $286 million in the opening quarter, a 46% improvement over Q4 2012’s tally.
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Therapeutic Areas
- Musculoskeletal & Connective Tissue Disorders
- North America
- Parent & Subsidiaries
- Baxano Surgical Inc.
- Senior Management
Ken Reali, Pres. & CEO
Joseph Slattery, EVP, CFO
Rick Feiler, VP, Mktg.
Stephen Ainsworth, PhD, VP, R&D
John Miller, VP, Sales
- Contact Info
Phone: (910) 332-1700
301 Government Center Dr.
Wilmington, NC 28403
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.